These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9696400)

  • 1. Galectin-3 and L1 retrotransposons in human breast carcinomas.
    Nangia-Makker P; Sarvis R; Visscher DW; Bailey-Penrod J; Raz A; Sarkar FH
    Breast Cancer Res Treat; 1998 May; 49(2):171-83. PubMed ID: 9696400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concomitant increases in galectin-1 and its glycoconjugate ligands (carcinoembryonic antigen, lamp-1, and lamp-2) in cultured human colon carcinoma cells by sodium butyrate.
    Ohannesian DW; Lotan D; Lotan R
    Cancer Res; 1994 Nov; 54(22):5992-6000. PubMed ID: 7954433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of galectin-3 suppresses tumorigenicity of human breast carcinoma cells.
    Honjo Y; Nangia-Makker P; Inohara H; Raz A
    Clin Cancer Res; 2001 Mar; 7(3):661-8. PubMed ID: 11297262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of tumorigenicity by galectin-3 in a nontumorigenic human breast-carcinoma cell-line.
    Nangiamakker P; Thompson E; Hogan C; Ochieng J; Raz A
    Int J Oncol; 1995 Nov; 7(5):1079-87. PubMed ID: 21552935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galectins-1 and -3 and their ligands in tumor biology. Non-uniform properties in cell-surface presentation and modulation of adhesion to matrix glycoproteins for various tumor cell lines, in biodistribution of free and liposome-bound galectins and in their expression by breast and colorectal carcinomas with/without metastatic propensity.
    André S; Kojima S; Yamazaki N; Fink C; Kaltner H; Kayser K; Gabius HJ
    J Cancer Res Clin Oncol; 1999; 125(8-9):461-74. PubMed ID: 10480338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-neuroblastoma antibody chCE7 binds to an isoform of L1-CAM present in renal carcinoma cells.
    Meli ML; Carrel F; Waibel R; Amstutz H; Crompton N; Jaussi R; Moch H; Schubiger PA; Novak-Hofer I
    Int J Cancer; 1999 Oct; 83(3):401-8. PubMed ID: 10495434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adhesion of human breast carcinoma to extracellular matrix proteins is modulated by galectin-3.
    Warfield PR; Makker PN; Raz A; Ochieng J
    Invasion Metastasis; 1997; 17(2):101-12. PubMed ID: 9561029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinoembryonic antigen and other glycoconjugates act as ligands for galectin-3 in human colon carcinoma cells.
    Ohannesian DW; Lotan D; Thomas P; Jessup JM; Fukuda M; Gabius HJ; Lotan R
    Cancer Res; 1995 May; 55(10):2191-9. PubMed ID: 7743523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of galectin-3 in breast cancer metastasis: involvement of nitric oxide.
    Song YK; Billiar TR; Lee YJ
    Am J Pathol; 2002 Mar; 160(3):1069-75. PubMed ID: 11891203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation of galectin-3 contributes to malignant transformation of human epithelial cells via modulation of unique sets of genes.
    Mazurek N; Sun YJ; Price JE; Ramdas L; Schober W; Nangia-Makker P; Byrd JC; Raz A; Bresalier RS
    Cancer Res; 2005 Dec; 65(23):10767-75. PubMed ID: 16322222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galectin-3 maintains the transformed phenotype of thyroid papillary carcinoma cells.
    Yoshii T; Inohara H; Takenaka Y; Honjo Y; Akahani S; Nomura T; Raz A; Kubo T
    Int J Oncol; 2001 Apr; 18(4):787-92. PubMed ID: 11251175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The NH2 terminus of galectin-3 governs cellular compartmentalization and functions in cancer cells.
    Gong HC; Honjo Y; Nangia-Makker P; Hogan V; Mazurak N; Bresalier RS; Raz A
    Cancer Res; 1999 Dec; 59(24):6239-45. PubMed ID: 10626818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alteration of the cytoplasmic/nuclear expression pattern of galectin-3 correlates with prostate carcinoma progression.
    van den Brûle FA; Waltregny D; Liu FT; Castronovo V
    Int J Cancer; 2000 Jul; 89(4):361-7. PubMed ID: 10956411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased expression of galectin-3 is associated with progression of human breast cancer.
    Castronovo V; Van Den Brûle FA; Jackers P; Clausse N; Liu FT; Gillet C; Sobel ME
    J Pathol; 1996 May; 179(1):43-8. PubMed ID: 8691344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galectin-3 regulates the adhesive interaction between breast carcinoma cells and elastin.
    Ochieng J; Warfield P; Green-Jarvis B; Fentie I
    J Cell Biochem; 1999 Dec; 75(3):505-14. PubMed ID: 10536372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and characterization of the major form of human MUC18 cDNA gene and correlation of MUC18 over-expression in prostate cancer cell lines and tissues with malignant progression.
    Wu GJ; Wu MW; Wang SW; Liu Z; Qu P; Peng Q; Yang H; Varma VA; Sun QC; Petros JA; Lim SD; Amin MB
    Gene; 2001 Nov; 279(1):17-31. PubMed ID: 11722842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions between galectin-3 and Mac-2-binding protein mediate cell-cell adhesion.
    Inohara H; Akahani S; Koths K; Raz A
    Cancer Res; 1996 Oct; 56(19):4530-4. PubMed ID: 8813152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galectin-3 overexpression protects from apoptosis by improving cell adhesion properties.
    Matarrese P; Fusco O; Tinari N; Natoli C; Liu FT; Semeraro ML; Malorni W; Iacobelli S
    Int J Cancer; 2000 Feb; 85(4):545-54. PubMed ID: 10699929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and regulation of galectin 3 in rat osteoblastic cells.
    Aubin JE; Gupta AK; Bhargava U; Turksen K
    J Cell Physiol; 1996 Dec; 169(3):468-80. PubMed ID: 8952696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of human cancer cell growth and metastasis in nude mice by oral intake of modified citrus pectin.
    Nangia-Makker P; Hogan V; Honjo Y; Baccarini S; Tait L; Bresalier R; Raz A
    J Natl Cancer Inst; 2002 Dec; 94(24):1854-62. PubMed ID: 12488479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.